22.4.22 Greenfern Industries has issued 877,659 ordinary shares under under GFI’s agreement with Cannvalate to satisfy in advance a first milestone of 1000 new patients. GFI’s agreement with Cannvalate is priced NZ$0.17090925 per Ordinary Share. (Calculated by reference to the 90-day volume weighted average price (VWAP) of the GFI's shares traded on the There is […]